Global Stem Cells Group’s mission is to become the world leader in adult stem cell therapies and physician training in stem cell protocols and medical procedures, and provide superior regenerative medicine products and supplies to the medical community. Our synergistic strategy positions us on the leading edge of stem cell research, physician education and patient care. The Global Stem Cells Group is the parent company of six, wholly owned operating companies, each administering to specific areas related to the stem cell industry.
These companies provide research, education, tools and medical procedures to physicians and patients interested in the many benefits of stem cell therapies. Founded in 2010, the company began as a patient advocacy and medical treatment platform to form a key part of the company’s overall strategy. The founder, Mr. Benito Novas leads the company as CEO. He is also the majority stockholder, and actively manages the day-to-day operations of the company. The Corporate headquarters for the Global Stem Cells Group is in Miami, Florida.
The Global Stem Cells Group is a stand out from many companies in the stem cell medicine arena in that we focus on serving our clients by delivering the most relevant cutting edge solutions. We are committed to balancing competitive pricing and providing solid economic gains for our shareholders. By providing the best cellular medicine services available, we believe that we are building a company that will create more value for our customers and our stockholders.
We pledge to adhere to the highest standards of integrity on behalf of our customers, our stockholders, and the world. We have created the optimal corporate structure to realize Global Stem Cell Group’s long-term potential, and we have established the appropriate financial controls and management oversight of our internal processes.
Stockholders may contact our board of directors by sending an email to email@example.com or by writing to the Corporate Secretary at the address below: